Clemastine
Back to searchMolecule Structure
Scientific Name
Clemastine
Description of the Drug
Clemastine is an antihistamine with sedative and anticholinergic effects used to treat the symptoms of allergic rhinitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00283
http://www.drugbank.ca/drugs/DB00283
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Glaxosmithkline Consumer Healthcare, Wockhardt Bio Ag, Teva Pharmaceuticals Usa Inc, Sandoz Inc, Pld Acquisitions Llc, Actavis Mid Atlantic Llc, Ani Pharmaceuticals Inc, L Perrigo Co, Teva Pharmaceuticals Usa
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4178 | ||
PharmGKB | PA164776997 | ||
Human Metabolome Database | HMDB0014428 | ||
DrugBank | DB00283 | ||
PubChem: Thomson Pharma | 14875878 | ||
PubChem | 26987 | ||
LINCS | LSM-2655 | ||
Nikkaji | J9.658J | ||
BindingDB | 94606 | 50253157 | |
EPA CompTox Dashboard | DTXSID2022832 | ||
DrugCentral | 671 | ||
ChemicalBook | CB3376056 | ||
Guide to Pharmacology | 6063 | ||
rxnorm | TAVIST | CLEMASTINE | CLEMASTINE FUMARATE |
KEGG Ligand | C06913 | ||
ChEBI | 3738 | ||
ZINC | ZINC000000402830 |